Product
NUC-7738
Name
NUC-7738
1 clinical trial
2 drugs
3 indications
Indication
Advanced CancerIndication
lymphomaIndication
Solid TumorDrug
ProTideClinical trial
A Phase I/II, Open-label, Dose-escalation and Expansion Study to Assess the Safety, Pharmacokinetics and Clinical Activity of NUC-7738, a Nucleotide Analogue, in Patients With Advanced Solid Tumours and LymphomaStatus: Recruiting, Estimated PCD: 2024-06-01